reviewTop 1% cited
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
Journal of Clinical Oncology · 2002 · Vol. 20(5) · pp. 1248–1259
Robert E. Bristow✉(Johns Hopkins University)Rafael S. Tomacruz(Johns Hopkins University)Deborah K. Armstrong(Johns Hopkins University)Edward L. Trimble(Johns Hopkins University)F.J. Montz(Johns Hopkins University)
Abstract
During the platinum era, maximal cytoreduction was one of the most powerful determinants of cohort survival among patients with stage III or IV ovarian carcinoma. Consistent referral of patients with apparent advanced ovarian cancer to expert centers for primary surgery may be the best means currently available for improving overall survival.
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometriosis Research and TreatmentMedicineCytoreductive surgeryOvarian carcinomaOncologyChemotherapyInternal medicineEpithelial ovarian carcinomaOvarian cancerOverall survivalCarcinoma
MeSH terms
AgedFemaleHumansMiddle AgedNeoplasm StagingOvarian NeoplasmsPlatinumPrognosisRegression Analysis
Citations
2,313
FWCI
52.21
field-weighted impact
References
106
Percentile
100%
vs. same field & year
Citations per year
Cited by
Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Annals of Surgical Oncology · 2006 · 418 citations
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer
Gynecologic Oncology · 2006 · 350 citations
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · 590 citations
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Gynecologic Oncology · 2006 · 398 citations
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
Cancer · 2009 · 1,581 citations
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Gynecologic Oncology · 2013 · 421 citations
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
Gynecologic Oncology · 2008 · 369 citations
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2013 · 1,110 citations
References
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
Gynecologic Oncology · 1992 · 553 citations
Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
Gynecologic Oncology · 1998 · 515 citations
Cancer Statistics, 2001
CA A Cancer Journal for Clinicians · 2001 · 3,319 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.